In recent years, the conversation around artificial intelligence has shifted from speculative fiction to strategic policy.

As tech and artificial intelligence reshape pharmacy operations, industry leaders call for guardrails to protect patient care ...

Dipanwita Das, CEO and co-founder of Sorcero, chats with Pharma Commerce to dig into the evolving drug development landscape, ...

MSFT, NVDA, and BAC lead Zacks' top stock picks, while microcaps BKTI and NRXS show surprising strength in niche markets.

Crowell and Moring’s new privacy and cybersecurity partner Mattew Ferraro, who previously served as the senior counselor for ...

MSFT, NVDA and BAC shine in Zacks' top picks, with AI, cloud, and higher rates driving strong growth projections.

Far from science fiction, AI is already embedded in hundreds of FDA-cleared tools and is projected to multiply the value of ...

David Sedaris, the well-known essay writer and humourist, wrote a piece a few years ago for The Paris Review called “A Number ...

WisdomTree Artificial Intelligence and Innovation Fund ETF has a competitive management fee with good diversification. Find ...

Punit Soni, a former Google executive and now CEO of Suki, a startup building A.I. assistants in healthcare, warns that ...

Marc Segura, president of ABB Robotics, shared his insights on the current trends in robotics — from AI-driven automation and ...